Key result
Review of 10 major ESC 2023 trials highlights significant clinical advances across cardiology.
Why the study?
More than 30 major clinical trials were presented at the ESC Congress 2023 with potential to alter practice, warranting a summary of key trials and their contemporary perspective.
This review provides a summary and contemporary perspective on 10 major practice-changing trials presented at the ESC Congress 2023.
The European Society of Cardiology annual congress is the premier global platform for dissemination and unraveling major scientific advances in the field of cardiology. Each year a myriad number of scientific ideas are exchanged at this meeting and many major path-breaking clinical trials are presented that have the potential to alter our practice. Last year was not different and more than 30 clinical trials spanning various facets of cardiology were unveiled and discussed-heart failure, lipid lowering, coronary intervention, intracoronary imaging, cardiomyopathies, anticoagulation, atrial fibrillation, antiplatelet therapy, etc. We present a brief summary of 10 major trials which in the view of authors have the potential for impacting daily cardiology practice. In each study, we also attempt to provide a contemporary perspective and the way forward. We aim to provide a glimpse on the major advances in the field of cardiology in the past year.
No takes yet. Share an insight, caveat, or question.
Pradhan et al. (2024) conducted a review in Cardiovascular disease. A review of 10 major clinical trials presented at the European Society of Cardiology Congress 2023 highlights significant advances across various facets of cardiology.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:
More on Sports cardiologyMore from International Journal of Angiology